Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
110,784,314
-
Total 13F shares
-
109,720,694
-
Share change
-
+28,023,346
-
Total reported value
-
$1,491,122,082
-
Put/Call ratio
-
37%
-
Price per share
-
$13.59
-
Number of holders
-
168
-
Value change
-
+$396,029,872
-
Number of buys
-
99
-
Number of sells
-
67
Institutional Holders of Amylyx Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (AMLX) as of Q3 2025
As of 30 Sep 2025 Amylyx Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (AMLX) had 168 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 109,720,694 shares of stock of the company.
Largest 10 holders included FMR LLC, PERCEPTIVE ADVISORS LLC, BlackRock, Inc., ADAGE CAPITAL PARTNERS GP, L.L.C., TCG Crossover Management, LLC, VANGUARD GROUP INC, Saturn V Capital Management LP, Commodore Capital LP, First Light Asset Management, LLC, and Point72 Asset Management, L.P..
This table shows 168 institutional shareholders of the security as of 30 Sep 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.